TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Decrease of metabolic activity as assessed by FDG PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stability of structural damage (radiography)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ct-values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of clinical symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Perfusion defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in BTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of emesis episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent's satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: acceptable aortic enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence of pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resourcefulness scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rate of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perforation area percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median direct cost per FET cycle
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median direct cost per live birth
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum levels of IL6, hsCRP and TNFα
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic response (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the PCL-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dropout from treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SNOT-25 total scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: PHQ-15 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of cerebrovascular events (stroke/TIA)
Endpoint domain: Mortality/survival
Primary endpoint: Total CVD events
Endpoint domain: Mortality/survival
Primary endpoint: incidence of hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: > 50% reduction in IBS-SSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PtCO2 difference between oxygen and room air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Knowledge of LVAD
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Values-treatment concordance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comprehensiveness of gatekeeper behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARFID severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients no longer meeting criteria for ARFID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective breastfeeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: timely union of fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systemic exposure of colistin (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total consumption of morphine equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children who had confidence in staying still for greater than 30 minutes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Discharge preparedness (B-PREPARED score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of transition (CTM-3 score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of diagnosis name AMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Narrative language proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in OSDI symptomology score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-output heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Chronic inflammatory status reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Proportion of participants with ≥50% reduction in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Prevalence of STH transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of time hearing aids were used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported proportion of time hearing aids were used
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: improvement in overall health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in dental fear/anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hard tissue healing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: connective tissue/bony healing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in FI episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of aortic dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Histopathologic concordance with SLB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soluble CD14 reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adiponectin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stiffness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H. pylori seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in standard deviation of normal to normal (SDNN) R‐R intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma iFGF23 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FC (Flea Count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FDI (Flea Density Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major complications incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with class content and activities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of classes and materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Applicability of materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Magnitude of increase in average ROE score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Magnitude of decrease in mean SCHNOS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Survival without severe cognitive disability
Endpoint domain: Mortality/survival
Primary endpoint: rates of biliary complications
Endpoint domain: Adverse events/effects
Primary endpoint: rates of infection
Endpoint domain: Adverse events/effects
Primary endpoint: mean incremental total cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean incremental QALYs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incremental effect of reduced health-related complaints with impact
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Different Doctor‐Patient Relationship Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Illness Management and Recovery–scale Client‐version scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain reduction in masseter and temporalis muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in muscle thickness of the bilateral masseter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease in muscle stiffness of the bilateral masseter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in postoperative trismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dementia-Related Quality of Life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diener's Flourishing Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infertility risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in review of care directive measures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in clinician-led care review discussions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Healing process after tooth extractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responsiveness to intensive therapies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of iron deficiency anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Postoperative pain reduction (VAS 0-4 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain reduction (VAS after 8 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain reduction (VAS after 24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstruation condition scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Systemic symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum sex hormone levels (FSH, LH, E2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: overall accuracy in 2- and 3-back tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: total reaction time during 3-back tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Moderate to severe grades of skin erythematous
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Instances of moist desquamation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: rescue dose of NSAID or opioids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: QUALID
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GAIN
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Shoulder pain and disability index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active abduction range of motion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: BPD symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHI emotional subscale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VSS (Vestibular Symptom Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IL-6 levels after RAI ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Th1+Th17/Th2+Th22 ratio in G2 patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-10 levels in G3 compared with G1 patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Causal effect of type 2 diabetes on cataract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Risk of cataract in type 2 diabetes patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: sensitivity to cold and touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee extension ROM and strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction of allodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TLF rates
Endpoint domain: Mortality/survival
Primary endpoint: Beta diversity differences in nasopharyngeal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accurate discrimination of CAP caused by bacteria, viruses, or mixed origin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 AUC 0-6 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MDS-UPDRS motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage change in striatal 18F-dopa uptake ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum NF-L concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of DVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived activation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median safe apnoea time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rate of CO2 accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma volume collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of significant hypotensive adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of CD4+ T-lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anxiety scores (HAMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life scores (QOL-DA)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sleep quality scores (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: femoral muscle volume loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median unbound concentrations in enhancing tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Median unbound concentrations in nonenhancing tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of progressive R-ALD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention-to-delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Birth rates at 6 h after oxytocin infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced risk of primary end point
Endpoint domain: Mortality/survival
Primary endpoint: total fat-free mass (FFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliable change in anxiety, depression, fatigue, sleep disturbance, and pain interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of small for gestational age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of preterm birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal complications
Endpoint domain: Adverse events/effects
Primary endpoint: speed for liver transection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood loss during transection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMDC risk group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD-L1 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of right-sided collisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of dermal thickness measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iHOT-33 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 4-week disability outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast contour aesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast shape evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capsular contracture classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seronegative rate after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: S1-specific IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anxiety level (VAS scores)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 3-month complete response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rectus abdominis thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abdominal muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pupae per person indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: B cell concentrations over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy measured by DAS28, ACR20/50/70, CDAI, SDAI, HAQ-DI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety regarding frequency, type and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Completion of recommended number of CBT sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Attendance of exercise sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completion of recommended exercise sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pacing capture threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EORTC QLQ-C30 GHS/QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median TTD in EORTC QLQ-C30 GHS/QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median TTD in EORTC QLQ-H&N35 pain and swallowing scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dominant hand grip strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RAPID3 Pain score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall joint symptoms remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of overall postoperative fistula (PF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WORC score at 10-year follow-up
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CDAI change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28-CRP change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GL-1 levels in cerebrospinal fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State anxiety pre- to postprocedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glycogen recovery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in pain end points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier resolution of COVID-19 related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional status on days 7 and 28 after discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Success rate of ultrasound-assisted LPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes